| Symbol | INMB |
|---|---|
| Name | INMUNE BIO, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL 33432 |
| Telephone | 8589643720 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001711754 |
| Description | None |
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
Read moreINmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
Read moreINmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimers Disease
Read moreINmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimers Disease
Read moreINmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech
Read moreINmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update
Read moreINmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update
Read moreINmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboratio
Read moreINmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
Read more